This guideline makes recommendations on Alzheimer’s disease, dementia with Lewy bodies (DLB), frontotemporal dementia, vascular dementia and mixed dementias, in addition to recommendations that apply to all types of dementia.
This comprehensive 2006/2007 guideline covers:
- The social model of dementia and experiences of care.
- Incidence, prevalence, aetiology, detection and assessment.
- Risks, abuse and neglect.
- Disclosure and stigma.
- Legal and ethical issues in connection with dementia care.
- The treatment and care of people with dementia in England and Wales.
- Palliative care, pain relief and care at the end of life for people.
- The economic cost of dementia.
- Health and social care recommendations and the services for people with dementia and their carers.
- Organising and planning services.
- The design of living and care environments.
- Prevention, early identification, assessment and diagnosis of dementia.
- Therapeutic interventions for people with dementia.
- Cognitive symptoms and maintenance of functioning.
- Strategies for promoting independence.
- Maintenance of cognitive function: psychological interventions.
- Acetylcholinesterase inhibitors or memantine for the treatment of cognitive symptoms of non-Alzheimer dementia.
- Other medicines for the treatment of cognitive symptoms of dementia.
- Medicines which control risk factors for vascular dementia for the treatment of cognitive symptoms of dementia.
- Qualitative evidence on the experiences of people with dementia and their carers of medication for the treatment of dementia.
- Non-cognitive symptoms and behaviour that challenges.
- Non-pharmacological interventions for challenging behaviour.
- Psychological interventions for people with dementia with depression or anxiety.
- Pharmacological interventions for non-cognitive symptoms of dementia and comorbid emotional disorders.
- Education for people with dementia, dementia care mapping, staff training and interventions for carers of people with dementia.
The CG42 Dementia guideline also includes seven appendices.
Note: This guideline has been updated as of March / April 2011.
National Collaborating Centre for Mental Health commissioned by the Social Care Institute for Excellence, National Institute for Health and Clinical Excellence. A NICE–SCIE Guideline on supporting people with dementia and their carers in health and social care (National Clinical Practice Guideline Number 42). London: The British Psychological Society & Gaskell and The Royal College of Psychiatrists, 2007.
Note: Dementia in Parkinson’s Disease has a number of similarities with dementia with Lewy bodies (DLB). While the evidence base for dementia in Parkinson’s Disease is not covered specifically in this guideline, the recommendations for DLB may be useful when considering treatments for dementia in Parkinson’s Disease. NICE has also produced a clinical guideline on Parkinson’s Disease (read more: http://www.nice.org.uk/nicemedia/live/10984/30087/30087.pdf).